Publications
554
Citations
12,972
Est. group size
~36
Recurring co-author estimate
Active years
21
Publishing since 2006
Jordan M. Cloyd's research focuses on the surgical treatment of liver, bile duct, pancreatic, and peritoneal cancers, including topics like hepatocellular carcinoma, cholangiocarcinoma, and pancreatic ductal adenocarcinoma. Much of the work examines treatment decision-making, such as neoadjuvant (pre-surgery) chemotherapy for pancreatic cancer, multidisciplinary tumor board processes, and outcomes after complex procedures like cytoreductive surgery with heated chemotherapy (HIPEC). The publication record also includes patient-centered topics such as care coordination, post-treatment anxiety, and palliative care within surgical oncology.
Publication output grew substantially from 2017 to a peak around 2020 and 2023, but has generally declined since 2023 through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Multidisciplinary Tumor Board Documentation: Assessing its Frequency, Quality, and Impact
Annals of Surgical Oncology · 2026
- Nonoperative Management of Hepatic Adenomas: A Review
Journal of Gastrointestinal Cancer · 2026
- ASO Visual Abstract: Multidisciplinary Tumor Board Documentation—Assessing its Frequency, Quality, and Impact
Annals of Surgical Oncology · 2026
- ASO Author Reflections: The Need for Improved Documentation at Multidisciplinary Tumor Boards
Annals of Surgical Oncology · 2026
- Locoregional Treatment Options for Locally Advanced Intrahepatic Cholangiocarcinoma
Journal of the National Comprehensive Cancer Network · 2025
- Predicting Severe Postoperative Complications after CRS‐HIPEC: An Externally Validated Machine‐Learning Tool
World Journal of Surgery · 2025
- Hepatic adenoma regression after bariatric surgery: a case series and systematic review
Surgical Endoscopy · 2025
- ASO Author Reflections: What is the Current Role for Palliative Care Within Surgical Oncology?
Annals of Surgical Oncology · 2025
- Recurrence after neoadjuvant therapy for pancreatic cancer: same challenges, new opportunities
HepatoBiliary Surgery and Nutrition · 2025
- Neoadjuvant mFOLFIRINOX for resectable pancreatic cancer: increasing evidence, ongoing challenges
Translational Gastroenterology and Hepatology · 2025
- Invited commentary on: “A fourth type of gastric neuroendocrine tumor: MaPPIng a distinct clinical entity”
Journal of Gastrointestinal Surgery · 2025
- Value in the treatment of primary and metastatic liver tumors: comparative cost-analysis of transarterial chemoembolization to transarterial radioembolization
HPB · 2025
- Surveillance-Associated Anxiety After Curative-Intent Cancer Surgery: A Systematic Review
Annals of Surgical Oncology · 2024
- Failure to Undergo Resection Following Neoadjuvant Therapy for Resectable Pancreatic Cancer: A Secondary Analysis of SWOG S1505
Journal of the National Comprehensive Cancer Network · 2024
- Patient Perceptions of Care Coordination during Neoadjuvant Therapy for Gastrointestinal Cancers: A Mixed Methods Analysis
Journal of Gastrointestinal Cancer · 2024
- Annals of Surgical Oncology×89
- HPB×70
- Journal of Gastrointestinal Surgery×58
- Journal of Surgical Oncology×27
- Gastroenterology×24
- Matthew J. Weiss
Medicine · The Ohio State University
- G. Martel
Medicine · The Ohio State University
- Aslam Ejaz
Medicine · The Ohio State University
- Bas Groot Koerkamp
Medicine · The Ohio State University
- J. Madison Hyer
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile